pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
Delivering for patients and sites in 2025 | pharmaphorum
6 天之前 · Sensorion encouraged by deafness gene therapy data. Sensorion's gene therapy for otoferlin-related hearing loss has shown early signs of improving hearing in two toddlers in a phase 1/2 trial.
PBM reform dropped in Congress' funding package | pharmaphorum
1 天前 · PBM reform looms in end-of-year US legislation package. Legislation that would introduce big changes for pharmacy benefit managers (PBMs) is inching closer to realisation in the US Congress.
PBM reform looms in end-of-year US legislation package
2024年12月17日 · PBM reform dropped in Congress' funding package. Proposed reforms to the regulations for PBMs were dropped from the US Congress' end-of-year bill to provide funding to the federal government.
Sign-up for pharma news alerts - pharmaphorum
The pharma world at your fingertips Daily News from pharmaphorum. Direct to your inbox – insights and analysis on the big trends shaping healthcare and pharma, with a focus on:
About pharmaphorum
5 天之前 · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep Dive. www.pharmaphorum.com
pharmaphorum - The Deep Dive Digital Magazine has fresh …
2024年2月28日 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Deep Dive: AI 2024 | pharmaphorum
2024年12月11日 · Deep Dive into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and the promise ...
Patients’ changing opinions of pharma - pharmaphorum
Respondents listed the industry’s achievements in R&D as the area where the most progress has been made in the last five years. It was the landslide winner, cited by 29% of those questioned, during a period which has seen the first gene therapies marketed, as …
Deep Dive: Patients & Partnerships 2024 | pharmaphorum
2 天之前 · Delve into the critical issues surrounding patients, partnerships, and the US election in 2024. Explore the impact on drug development, pricing, and patient access in this in-depth analysis.